Literature DB >> 3060147

Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor I (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).

H Fritz1.   

Abstract

Human mucous secretions contain a proteinase inhibitor which is produced locally and inhibits, besides trypsin and chymotrypsin, granulocytic elastase and cathepsin G as well as mast cell chymase and tryptase. The various inhibitors isolated from different sources (bronchial mucus, parotid secretion, seminal plasma, cervical mucus, etc.) and named accordingly (bronchial mucus inhibitor, BMI; human seminal inhibitor I, HUSI-I; cervical mucus inhibitors, CUSI; antileukoprotease, ALP; secretory leukocyte protease inhibitor, SLPI) proved to be identical or derived from a mature inhibitory protein encoded by a single gene of the human genom. Therefore, this inhibitor should be named mucus proteinase inhibitor, MPI. Such a neutral terminus would help to avoid misleading interpretations of already published data and also of the biological role of this inhibitory protein because the MPI may serve several and different physiological functions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060147

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  20 in total

1.  Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor.

Authors:  M S Mulligan; A B Lentsch; M Huber-Lang; R F Guo; V Sarma; C D Wright; T R Ulich; P A Ward
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.

Authors:  M S Pate; S R Hedges; D A Sibley; M W Russell; E W Hook; J Mestecky
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

3.  Secretory leukocyte protease inhibitor interferes with uptake of lipopolysaccharide by macrophages.

Authors:  A Ding; N Thieblemont; J Zhu; F Jin; J Zhang; S Wright
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Lipopolysaccharide-related stimuli induce expression of the secretory leukocyte protease inhibitor, a macrophage-derived lipopolysaccharide inhibitor.

Authors:  F Jin; C F Nathan; D Radzioch; A Ding
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.

Authors:  C Vogelmeier; R C Hubbard; G A Fells; H P Schnebli; R C Thompson; H Fritz; R G Crystal
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

6.  Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

Authors:  S M Wahl; P Worley; W Jin; T B McNeely; S Eisenberg; C Fasching; J M Orenstein; E N Janoff
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

7.  Alpha 1-proteinase inhibitor and mucus proteinase inhibitor in human lung emphysema.

Authors:  G Trefz; J Schliesser; B Heck; V Schulz; W Ebert
Journal:  Clin Investig       Date:  1992 Mar-Apr

8.  Evolution of trappin genes in mammals.

Authors:  Akira Kato; Alejandro P Rooney; Yutaka Furutani; Shigehisa Hirose
Journal:  BMC Evol Biol       Date:  2010-01-29       Impact factor: 3.260

9.  Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.

Authors:  R J Playford; J J Batten; T C Freeman; K Beardshall; D A Vesey; G C Fenn; J H Baron; J Calam
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

10.  Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.

Authors:  M Maruyama; J G Hay; K Yoshimura; C S Chu; R G Crystal
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.